Nexavar

ASCO: With Opdivo-Yervoy combo, Bristol Myers calls Roche and AstraZeneca's bets in first-line liver cancer
Fierce Pharma
Tue, 06/4/24 - 11:52 am
ASCO 2024
Bristol Myers Squibb
Opdivo
Yervoy
liver cancer
Merck
Eisai
Bayer
Lenvima
Nexavar
In surprising flop, Exelixis' Cabometyx combo with Roche's Tecentriq fails to extend life in liver cancer
Fierce Pharma
Mon, 06/28/21 - 10:50 am
Exelixis
Cabometyx
liver cancer
Bayer
Nexavar
Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer
Endpoints
Mon, 11/25/19 - 09:47 am
Roche
Tecentriq
Avastin
liver cancer
China
Bayer
Nexavar
clinical trials
Roche's Tecentriq scores a first-in-class double win in new liver cancer patients
Fierce Pharma
Mon, 10/21/19 - 04:36 pm
Roche
liver cancer
Tecentriq
immuno-oncology
Avastin
Nexavar
Bristol-Myers star Opdivo fails survival test in a matchup with Nexavar aimed at shaking up the big HCC market
Endpoints
Mon, 06/24/19 - 11:25 am
Bristol-Myers Squibb
Opdivo
Bayer
Nexavar
liver cancer
clinical trials
Two weeks after Trump unveiled plan to lower drug prices, two cancer drugs got a $1,000-per-month price hike
Washington Post, DC
Fri, 06/8/18 - 11:41 pm
Bayer
drug pricing
Nexavar
Stivarga
Eisai's Lenvima nabs survival edge in liver cancer showdown with Bayer's Nexavar
Fierce Pharma
Sun, 06/4/17 - 11:51 am
Eisai
Lenvima
liver cancer
Bayer
Nexavar
ASCO 2017
As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters
Fierce Pharma
Sat, 03/11/17 - 11:55 am
Bayer
intellectual property
India
exporting
Xarelto
Nexavar
Bayer growth hope Stivarga boosts survival in liver cancer patients
Fierce Pharma
Wed, 06/29/16 - 10:50 am
Bayer
Stivarga
liver cancer
Nexavar
hepatocellular carcinoma
Can Eisai pump its thyroid cancer pill to $1B in sales? Rival Bayer might object
Fierce Pharma Marketing
Wed, 02/18/15 - 10:50 am
Eisai
Bayer
thyroid cancer
Lenvima
Nexavar
Bayer loses bid to block cheap version of cancer drug in India
FT.com
Fri, 12/12/14 - 12:37 pm
Bayer
India
Nexavar
Bayer, Onyx Pharma Say Phase 3 Trial Of NEXAVAR Fails To Meet Primary Endpoint
RTT News
Fri, 07/25/14 - 11:11 am
Bayer
ONYX Pharmaceuticals
Nexavar
breast cancer
Cancer drugs from J&J, Roche, Celgene and more rival last big oncology wave
Fierce Pharma Marketing
Thu, 05/8/14 - 12:30 pm
oncology
JNJ
Roche
Celgene
Zytiga
Kadcyla
Nexavar
Gleevec
EU agency backs GSK melanoma drug, wider use of Bayer's Nexavar
Yahoo/Reuters
Fri, 04/25/14 - 11:02 am
GSK
melanoma
Europe
Bayer
Nexavar
Mekinist
thyroid cancer
Bayer, Onyx Report Primary Endpoint of Phase 3 Study Results of NEXAVAR as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation was Not Met
Bloomberg
Tue, 03/11/14 - 08:22 am
Bayer
ONYX Pharmaceuticals
Nexavar
liver cancer
U.S. FDA Approves NEXAVAR (sorafenib) for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory to Radioactive Iodine Treatment
Yahoo/PR NewsWire
Sat, 11/23/13 - 12:06 pm
Nexavar
Bayer
ONYX Pharmaceuticals
Amgen
thyroid cancer
refractory differential thyroid cancer
Bayer's Nexavar gets priority review as thyroid cancer drug
Reuters
Tue, 08/27/13 - 09:31 am
Bayer
Nexavar
thyroid cancer
Onyx Jumps After Report Amgen Considers Acquisition
Bloomberg
Fri, 06/28/13 - 06:50 pm
Amgen
M&A
ONYX Pharmaceuticals
Nexavar
Two Diversified Biotechs to Watch After Impressive ASCO Data
Motley Fool
Mon, 06/3/13 - 12:36 pm
ONYX Pharmaceuticals
Nexavar
tergenpumatucel-L
NewLink Genetics
ASCO
Bayer's (and ONYX's) Nexavar shown to delay thyroid cancer by 5 months
Reuters
Sun, 06/2/13 - 11:38 am
thyroid cancer
Nexavar
Bayer
ONYX Pharmaceuticals

Pages